Research Analysts Set Expectations for SurgePays Q1 Earnings

SurgePays, Inc. (NASDAQ:SURG) – Analysts at Sidoti Csr cut their Q1 2025 earnings per share (EPS) estimates for SurgePays in a note issued to investors on Wednesday, March 26th. Sidoti Csr analyst A. Soderstrom now expects that the medical equipment provider will post earnings per share of ($0.35) for the quarter, down from their prior forecast of ($0.19). The consensus estimate for SurgePays’ current full-year earnings is ($1.66) per share. Sidoti Csr also issued estimates for SurgePays’ Q2 2025 earnings at ($0.28) EPS, Q3 2025 earnings at ($0.10) EPS, FY2025 earnings at ($0.67) EPS, Q2 2026 earnings at $0.21 EPS, Q3 2026 earnings at $0.21 EPS, Q4 2026 earnings at $0.22 EPS and FY2026 earnings at $0.83 EPS.

Separately, Ascendiant Capital Markets lowered their price objective on shares of SurgePays from $9.00 to $8.50 and set a “buy” rating for the company in a research report on Monday, December 16th.

SurgePays Trading Down 7.2 %

SURG stock opened at $2.18 on Friday. The firm has a fifty day moving average price of $1.41 and a 200 day moving average price of $1.62. SurgePays has a fifty-two week low of $1.05 and a fifty-two week high of $4.38. The firm has a market cap of $43.95 million, a PE ratio of -1.93 and a beta of 1.03. The company has a debt-to-equity ratio of 0.08, a quick ratio of 4.70 and a current ratio of 6.24.

SurgePays (NASDAQ:SURG) last announced its quarterly earnings results on Tuesday, March 25th. The medical equipment provider reported ($0.93) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.66). SurgePays had a negative net margin of 27.39% and a negative return on equity of 55.63%. The firm had revenue of $9.59 million for the quarter, compared to the consensus estimate of $8.22 million.

Institutional Investors Weigh In On SurgePays

Several large investors have recently added to or reduced their stakes in SURG. Geode Capital Management LLC increased its position in shares of SurgePays by 5.5% during the 4th quarter. Geode Capital Management LLC now owns 156,115 shares of the medical equipment provider’s stock valued at $278,000 after purchasing an additional 8,097 shares during the last quarter. Virtu Financial LLC purchased a new position in SurgePays during the third quarter worth $25,000. Renaissance Technologies LLC increased its position in SurgePays by 43.6% during the fourth quarter. Renaissance Technologies LLC now owns 49,400 shares of the medical equipment provider’s stock valued at $88,000 after acquiring an additional 15,000 shares during the last quarter. Truvestments Capital LLC raised its stake in shares of SurgePays by 20.1% in the fourth quarter. Truvestments Capital LLC now owns 102,002 shares of the medical equipment provider’s stock valued at $182,000 after acquiring an additional 17,056 shares during the period. Finally, Northern Trust Corp lifted its holdings in shares of SurgePays by 67.4% in the 4th quarter. Northern Trust Corp now owns 63,269 shares of the medical equipment provider’s stock worth $113,000 after acquiring an additional 25,467 shares during the last quarter. 6.94% of the stock is owned by institutional investors.

SurgePays Company Profile

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.